Elixinol Wellness Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was AUD 4.790 million compared to AUD 7.850 million a year ago. Net loss was AUD 10.828 million compared to AUD 90.302 million a year ago. Basic loss per share from continuing operations was AUD 0.0345 compared to AUD 0.6051 a year ago.